Adhd
Conditions
Brief summary
The investigators hypothesize that the mindfulness Cognitive Behavioral Therapy program will lead to a reduction in attention deficit and hyperactivity disorder symptoms, anxiety and depression, and improve self-confidence, emotional control, social integration and school results.
Interventions
16 simultaneous-but-separate therapy sessions for parents and children.
Sponsors
Study design
Eligibility
Inclusion criteria
* If deemed able, the patient must have given his/her informed and signed consent * The parents (or legal guardian) of minor patients must have given their informed and signed consent. * The patient and participating parents must be insured or beneficiary of a health insurance plan * The patient is equal to or greater than 7 years old and less than or equal to 15 years old * The patient presents with attention deficit and hyperactivity disorder with an ADHDRS-PI score \> 27 * The patient is currently not under treatment - OR - is treated with methylphenidate with a stable posology (not expected to vary in the near future) but remains symptomatic
Exclusion criteria
* The patient is participating in, or has participated in over the past three months, another trial or another study that may interfere with the results or conclusion of the present study * The patient is in an exclusion period determined by a previous study * The participating parent(s) is(are) under judicial protection, or is an adult under guardianship * It is impossible to correctly inform the patient or his/her parent or legal guardian * Patients or parents refusing participation, signature of the signed consent or follow-up procedures * Previously documented mental retardation (IQ \< 70) or suspicion thereof by the investigator * The patient has already participated in cognitive behavioural therapy (individual or group) in the six months preceding inclusion * Patients diagnosed with autism spectrum disorder, psychotic disorder or bipolar disorder * The family has participated in a parental guidance programme in the last 6 months. * The family has already participated in the present study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| ADHD symptom severity | baseline | clinical-rated ADHD rating scale (ADHDRS-PI) questionnaire; score ranges 0-54 |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The quality of life for parents. | Baseline | Parental - Developmental Disorders - Quality of Life (PAR-DD-QoL) questionnaire; score ranges from 17-85 |
| Global function | Baseline | Clinical Global Impression Scale (CGI-S) questionnaire; score from 1-7 |
| Social well-being and school parameters for children | Baseline | CONNERS for school teachers; cut-off for significant behavioral problem \>15 his questionnaire will be given to the first patients included to 149 th patient included |
| Parenting styles | Baseline | Parental Authority Questionnaire (PAQ); 30 items per parent |
| Depression in children | Baseline | Children depression inventory (CDI) questionnaire; score ranges from 0-54 |
| Anxiety and depression in parents | Baseline | Hospital Anxiety and Depression Scale (HADS) questionnaire; 2 subscores each ranging from 0-21 |
| Self-Esteem and behaviour for children. | Baseline | Rosenberg scale; score ranges from 0-40 |
| Anxiety in children | Baseline | Multidimensional Anxiety Scale for Children (MASC) questionnaire; 39-item, 4-point Likert scale |
Countries
France